ly3537982
eli lilly
['ly3537982', 'solid tumor']
#aacr23 | chapin theater-convention center | monday
ct028 - a first-in-human phase 1 study of ly3537982, a highly selective and potent kras g12c inhibitor in patients with kras g12c-mutant advanced solid tumors 
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham.